Le Lézard
Classified in: Environment, Health
Subject: PDT

ProGro BIO Launches Expansive 2024 U.S.-Wide Rhizol Soil Inoculant In-Field Trials


ATLANTA, May 10, 2024 /PRNewswire/ -- ProGro BIO has announced the commencement of its 2024 U.S. expansive in-field trial program. Building upon the resounding success of its 2023 program, which encompassed over 10,000 acres across diverse crops, this year's initiative marks another milestone in ProGro BIO's commitment to supporting and expanding regenerative agricultural practices.

ProGro Launches Large U.S.-Based In-Field Program

The 2024 program, which has already been fully subscribed, aims to further showcase the efficacy of ProGro BIO's groundbreaking natural organic microbial soil inoculant, Rhizol. Comprised of 35 potent microbial isolates in highly concentrated form, Rhizol rejuvenates soil biodiversity paving the way for enhanced crop performance, yields, and support of regenerative farming practices.

Zach Lancaster, ProGro BIO Field Director, expressed enthusiasm for the 2024 program, stating, "On the heels of our successful 2023 program, interest in ProGro's 2024 in program has been extremely well received.  Buoyed by the success of last year's program, we are significantly expanding into new geographies and markets with our 2024 program. With over 370 plots across 20 states, this year's program engages participants from all sectors of agriculture including growers, consultants, universities, and research organizations. Our In-Field programs provide first-hand experience with Rhizol for farmers and crop consultants across the country paired with third-party supervision and data analysis".

In 2023, ProGro BIO launched one of the largest agricultural in-field trial programs in recent history, spanning 22 states and encompassing numerous crop types. Results from the program demonstrated significant findings including expanded root systems and growth at the seedling stage, accelerated early season vigor, expedited foliar formation and leaf development, increased fruiting activity in the reproductive growth phase and impressive net increases in crop yields. The company launched full commercial sales activities for the 2024 spring planting season.

For more information about ProGro BIO and its innovative agricultural solutions, please visit https://www.progrobio.com.

About ProGro BIO
With a focus on soil health and crop productivity, ProGro BIO produces an innovative line of all-natural soil inoculants designed to dramatically enhance biodiversity and resilience in agricultural ecosystems. The company's all-natural organic microbial formulations are the most advanced formulations of beneficial bacterial and fungal strains available on the market. Rhizol is the result of three decades of research and development and testing that when properly applied can increase crop yields, accelerate plant growth, strengthen soil to better defend against soil-borne pathogens and destructive parasitic nematodes, and perpetuate drought resistance. Learn more at www.progrobio.com.

SOURCE ProGro BIO Inc.


These press releases may also interest you

at 14:20
The global gastroesophageal reflux disease (GERD) market  size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.2%  during the forecast period.  Rising geriatric...

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...



News published on and distributed by: